CERT
Certara IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$860.95M
P/E Ratio
—
EPS
$-0.01
Beta
1.62
52W High
$15.38
52W Low
$5.19
50-Day MA
$7.00
200-Day MA
$9.64
Dividend Yield
—
Profit Margin
-0.38%
Forward P/E
12.67
PEG Ratio
—
About Certara Inc
Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.
Fundamentals
| Revenue (TTM) | $418.84M |
| Gross Profit (TTM) | $257.71M |
| EBITDA | $98.47M |
| Operating Margin | 2.08% |
| Return on Equity | -0.15% |
| Return on Assets | 0.93% |
| Revenue/Share (TTM) | $2.61 |
| Book Value | $6.68 |
| Price-to-Book | 0.81 |
| Price-to-Sales (TTM) | 2.06 |
| EV/Revenue | 2.326 |
| EV/EBITDA | 9.50 |
| Quarterly Earnings Growth (YoY) | -14.10% |
| Quarterly Revenue Growth (YoY) | 3.30% |
| Shares Outstanding | $153.32M |
| Float | $118.83M |
| % Insiders | 2.50% |
| % Institutions | 115.13% |
Historical Volatility
HV 10-Day
43.55%
HV 20-Day
40.20%
HV 30-Day
40.28%
HV 60-Day
41.07%
HV Rank
12.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.99 target)
1
Strong Buy6
Buy7
HoldData last updated: 4/10/2026